Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Puma Biotechnology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +2 vs. Q2 2024
- Shares held
- 29.8M
- +2.37M (+8.6%) vs. Q2 2024
- Total value
- $76.0M
- −$13.4M (−15.0%) vs. Q2 2024
- New holders
- 19
- 33 more added
- Sold out
- 17
- 23 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBYI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $313.6M |
| Q1 2026 | 157 | $241.8M |
| Q4 2025 | 151 | $210.2M |
| Q3 2025 | 132 | $182.6M |
| Q2 2025 | 121 | $112.8M |
| Q1 2025 | 116 | $90.1M |
| Q4 2024 | 112 | $90.1M |
| Q3 2024 | 100 | $76.0M |
| Q2 2024 | 99 | $101.0M |
| Q1 2024 | 93 | $164.4M |
| Q4 2023 | 82 | $117.0M |
| Q3 2023 | 69 | $67.6M |
| Q2 2023 | 68 | $93.8M |
| Q1 2023 | 78 | $86.3M |
| Q4 2022 | 89 | $116.3M |
| Q3 2022 | 83 | $65.5M |
| Q2 2022 | 89 | $79.5M |
| Q1 2022 | 104 | $86.1M |
| Q4 2021 | 102 | $93.1M |
| Q3 2021 | 116 | $226.0M |
| Q2 2021 | 120 | $319.3M |
| Q1 2021 | 118 | $355.9M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Puma Biotechnology, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Great Point Partners LLC | 0 | $0 | 0.00% | −1,486,544−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −256,263−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −200,085−100.0% | Sold out |
| Rice Hall James & Associates, LLC | 0 | $0 | 0.00% | −144,792−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −140,205−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −117,665−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −92,174−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −70,352−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −40,116−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −32,668−100.0% | Sold out |
| Brandywine Global Investment Management, LLC | 0 | $0 | 0.00% | −32,210−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −21,007−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −17,765−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −14,236−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −10,973−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,498−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |